Pulmonary Fibrosis
The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this more true than in the elucidation and verification of the pathogenetic basis upon which they develop. Scientific progress, most recently in the field of experimental therapy, has relied closely on interpreting data derived from animal modeling. Such models are used to identify the cellular interactions and molecular pathways involved in lung tissue repair and fibrosis. Over the coming years, the significance of new discoveries will continue to be evaluated using the in vivo analysis of animal models substituting for patients with actual pulmonary fibrosis. The commonest strategy to induce experimental pulmonary fibrosis is by directly administering a profibrotic agent to either wild-type animals or those that bear a specific genetic modification. The creation of new models has been greatly enhanced by the availability of stem cell lines and methods for introducing genetic mutations into these cells. Despite an increasing choice of models, there are still good reasons to continue adapting and using one of its earliest examples, the bleomycin model, in post-genomic pulmonary fibrosis research. A brief review of the exacting requirements of such research will place the strengths of this particular model in perspective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pulmonary fibrosis is also included in the host response to reverse the loss of essential metal after its sequestration by asbestos (Figure 3 and Figure 4) [64].”
From Asbestos and Iron (2023) · cites this paper as [64]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Self-citationLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Resolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Kaminski, N., Allard, J. D., Pittet, J. F., Zuo, F., Griffiths, M. J. D., Morris, D., Huang, X., Sheppard, D., & Heller, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1778 · Cited by 417
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Research works printed but not linked: 5
- 1993, Monogr Pathol, 36, 78
- 2002, Respir Res, 3, 1
- 1978, Am Rev Respir Dis, 117, 289
- 1996, Lab Invest, 74, 12
- 1993, Thorax, 48, 956
Cited by
Moeller, A., Ask, K., Warburton, D., Gauldie, J., & Kolb, M. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.08.011 · Cited by 1,007
Self-citationStandardized Quantification of Pulmonary Fibrosis in Histological Samples
Hübner, R.-H., Gitter, W., Eddine El Mokhtari, N., Mathiak, M., Both, M., Bolte, H., Freitag-Wolf, S., & Bewig, B. (2008) · BioTechniques · doi:10.2144/000112729 · Cited by 817
“Animal models using bleomycin are an important tool for the analysis of pathogenetic processes in lung fibrosis and for the evaluation of new antifibrotic drugs (6,7), although processes involved in idiopathic pulmonary fibrosis (IPF) may not be identical (8).”
BackgroundMethodRegulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Self-citationFunctional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
Königshoff, M., Balsara, N., Pfaff, E.-M., Kramer, M., Chrobak, I., Seeger, W., & Eickelberg, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002142 · Cited by 507
Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis
Henderson, W. R., Chi, E. Y., Ye, X., Nguyen, C., Tien, Y.-T., Zhou, B., Borok, Z., Knight, D. A., & Kahn, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001520107 · Cited by 462
Antifibrotic activities of pirfenidone in animal models
Schaefer, C. J., Ruhrmund, D. W., Pan, L., Seiwert, S. D., & Kossen, K. (2011) · European Respiratory Review · doi:10.1183/09059180.00001111 · Cited by 454
Jenkins, R. G., Moore, B. B., Chambers, R. C., Eickelberg, O., Königshoff, M., Kolb, M., Laurent, G. J., Nanthakumar, C. B., Olman, M. A., Pardo, A., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0096st · Cited by 435
Self-citationMolecular and cellular mechanisms of pulmonary fibrosis
Todd, N. W., Luzina, I. G., & Atamas, S. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-11 · Cited by 418
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model
Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 358
The Bleomycin Model of Pulmonary Fibrosis
Liu, T., De Los Santos, F. G., & Phan, S. H. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7113-8_2 · Cited by 357
The Role of Inflammation in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Bringardner, B. D., Baran, C. P., Eubank, T. D., & Marsh, C. B. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1897 · Cited by 311
Blockade of IL-6 Trans Signaling Attenuates Pulmonary Fibrosis
Le, T.-T. T., Karmouty-Quintana, H., Melicoff, E., Le, T.-T. T., Weng, T., Chen, N.-Y., Pedroza, M., Zhou, Y., Davies, J., Philip, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302470 · Cited by 299
“This model of chronic bleomycin exposure has been demonstrated to recapitulate features of IPF, such as the presence of hyperplastic airway epithelial cells and fibrosis that radiates inward from the pleural surfaces and is progressive, irreversible, and lethal (51, 52).”
Participation of miR-200 in Pulmonary Fibrosis
Yang, S., Banerjee, S., de Freitas, A., Sanders, Y. Y., Ding, Q., Matalon, S., Thannickal, V. J., Abraham, E., & Liu, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.005 · Cited by 259
Cargnoni, A., Gibelli, L., Tosini, A., Signoroni, P. B., Nassuato, C., Arienti, D., Lombardi, G., Albertini, A., Wengler, G. S., & Parolini, O. (2009) · Cell Transplantation · doi:10.3727/096368909788809857 · Cited by 240
Atabai, K., Jame, S., Azhar, N., Kuo, A., Lam, M., McKleroy, W., DeHart, G., Rahman, S., Xia, D. D., Melton, A. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40053 · Cited by 237
Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis
Redente, E. F., Jacobsen, K. M., Solomon, J. J., Lara, A. R., Faubel, S., Keith, R. C., Henson, P. M., Downey, G. P., & Riches, D. W. H. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00122.2011 · Cited by 215
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P
Pilling, D., Roife, D., Wang, M., Ronkainen, S. D., Crawford, J. R., Travis, E. L., & Gomer, R. H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4035 · Cited by 230
“Bleomycin-induced lung fibrosis is the most frequently used rodent model of lung fibrosis, and produces inflammatory and fibrotic events similar to those seen in human pulmonary fibrosis (7).”
BackgroundThe importance of interventional timing in the bleomycin model of pulmonary fibrosis
Kolb, P., Upagupta, C., Vierhout, M., Ayaub, E., Bellaye, P. S., Gauldie, J., Shimbori, C., Inman, M., Ask, K., & Kolb, M. R. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.01105-2019 · Cited by 208
Self-citationBaran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1279oc · Cited by 196
Rege, T. A., & Hagood, J. S. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.08.008 · Cited by 182
Aguilar, S., Scotton, C. J., McNulty, K., Nye, E., Stamp, G., Laurent, G., Bonnet, D., & Janes, S. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008013 · Cited by 171
Self-citationMicrocystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization
Wang, J., Xu, L., Xiang, Z., Ren, Y., Zheng, X., Zhao, Q., Zhou, Q., Zhou, Y., Xu, L., & Wang, Y. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2329-z · Cited by 171
Cigarette Smoke Drives Small Airway Remodeling by Induction of Growth Factors in the Airway Wall
Churg, A., Tai, H., Coulthard, T., Wang, R., & Wright, J. L. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-585oc · Cited by 173
Gene Expression Profiling of Familial and Sporadic Interstitial Pneumonia
Yang, I. V., Burch, L. H., Steele, M. P., Savov, J. D., Hollingsworth, J. W., McElvania-Tekippe, E., Berman, K. G., Speer, M. C., Sporn, T. A., Brown, K. K., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200601-062oc · Cited by 171
Intratracheal Transplantation of Alveolar Type II Cells Reverses Bleomycin-induced Lung Fibrosis
Serrano-Mollar, A., Nacher, M., Gay-Jordi, G., Closa, D., Xaubet, A., & Bulbena, O. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1491oc · Cited by 166
“Hence this model has been widely used to study the regulation of lung fibrosis (12).”
MethodMice Lacking Neutrophil Elastase Are Resistant to Bleomycin-Induced Pulmonary Fibrosis
Chua, F., Dunsmore, S. E., Clingen, P. H., Mutsaers, S. E., Shapiro, S. D., Segal, A. W., Roes, J., & Laurent, G. J. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060352 · Cited by 159
Self-citationNakagome, K. (2006) · Thorax · doi:10.1136/thx.2005.056317 · Cited by 159
Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
Jiang, D., Liang, J., Campanella, G. S., Guo, R., Yu, S., Xie, T., Liu, N., Jung, Y., Homer, R., Meltzer, E. B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38644 · Cited by 159
Engineered cell and tissue models of pulmonary fibrosis
Sundarakrishnan, A., Chen, Y. G., Black, L. D., Aldridge, B. B., & Kaplan, D. L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.013 · Cited by 164
Hemnes, A. R., Zaiman, A., & Champion, H. C. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00245.2007 · Cited by 157
Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis. Potential for Clinical Testing
Toonkel, R. L., Hare, J. M., Matthay, M. A., & Glassberg, M. K. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1204pp · Cited by 143
Transgelin is a direct target of TGF‐β/Smad3‐dependent epithelial cell migration in lung fibrosis
Yu, H., Königshoff, M., Jayachandran, A., Handley, D., Seeger, W., Kaminski, N., & Eickelberg, O. (2008) · The FASEB Journal · doi:10.1096/fj.07-083857 · Cited by 146
Interstitial lung diseases in children
Clément, A., Nathan, N., Epaud, R., Fauroux, B., & Corvol, H. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-22 · Cited by 161
Epigenetics of idiopathic pulmonary fibrosis
Yang, I. V., & Schwartz, D. A. (2015) · Translational Research · doi:10.1016/j.trsl.2014.03.011 · Cited by 139
Smad3 Signaling Involved in Pulmonary Fibrosis and Emphysema
Gauldie, J., Kolb, M., Ask, K., Martin, G., Bonniaud, P., & Warburton, D. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-125sf · Cited by 145
Self-citationMale Sex Hormones Exacerbate Lung Function Impairment after Bleomycin-Induced Pulmonary Fibrosis
Voltz, J. W., Card, J. W., Carey, M. A., DeGraff, L. M., Ferguson, C. D., Flake, G. P., Bonner, J. C., Korach, K. S., & Zeldin, D. C. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0340oc · Cited by 138
Antioxidants as Potential Therapeutics for Lung Fibrosis
Day, B. J. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1916 · Cited by 138
Egger, C., Cannet, C., Gérard, C., Jarman, E., Járai, G., Feige, A. H., Suply, T., Micard, A., Dunbar, A., Tigani, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063432 · Cited by 143
Wang, K., Zhang, T., Lei, Y., Li, X., Jiang, J., Lan, J., Liu, Y., Chen, H., Gao, W., Xie, N., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1409405 · Cited by 134
Parolini, O., Alviano, F., Bergwerf, I., Boraschi, D., Bari, C. D., Waele, P. D., Dominici, M., Evangelista, M., Falk, W., Hennerbichler, S., et al. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0404 · Cited by 139
Immune Mechanisms of Pulmonary Fibrosis with Bleomycin
Ishida, Y., Kuninaka, Y., Mukaida, N., & Kondo, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043149 · Cited by 137
Ma, T., Li, X., Zhu, Y., Yu, S., Liu, T., Zhang, X., Chen, D., Du, S., Chen, T., Chen, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835879 · Cited by 148
Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice
Redente, E. F., Black, B. P., Backos, D. S., Bahadur, A. N., Humphries, S. M., Lynch, D. A., Tuder, R. M., Zemans, R. L., & Riches, D. W. H. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0542ma · Cited by 120
Sahin, H., & Wasmuth, H. E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.004 · Cited by 114
Proapoptotic Bid is required for pulmonary fibrosis
Budinger, G. R. S., Mutlu, G. M., Eisenbart, J., Fuller, A. C., Bellmeyer, A. A., Baker, C. M., Wilson, M., Ridge, K., Barrett, T. A., Lee, V. Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507604103 · Cited by 109
Transcriptional Coactivator with PDZ-binding Motif Is Essential for Normal Alveolarization in Mice
Mitani, A., Nagase, T., Fukuchi, K., Aburatani, H., Makita, R., & Kurihara, H. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1827oc · Cited by 105
Jain, M., Budinger, G. R. S., Lo, A., Urich, D., Rivera, S. E., Ghosh, A. K., Gonzalez, A., Chiarella, S. E., Marks, K., Donnelly, H. K., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201009-1409oc · Cited by 107
c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
Alcorn, J. F., van der Velden, J., Brown, A. L., McElhinney, B., Irvin, C. G., & Janssen-Heininger, Y. M. W. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0174oc · Cited by 98
Extracellular matrix proteins: A positive feedback loop in lung fibrosis?
Blaauboer, M. E., Boeijen, F. R., Emson, C. L., Turner, S. M., Zandieh-Doulabi, B., Hanemaaijer, R., Smit, T. H., Stoop, R., & Everts, V. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.11.002 · Cited by 98
Disease-Specific Gene Expression Profiling in Multiple Models of Lung Disease
Lewis, C. C., Yang, J. Y. H., Huang, X., Banerjee, S. K., Blackburn, M. R., Bałuk, P., McDonald, D. M., Blackwell, T. S., Nagabhushanam, V., Peters, W., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200702-333oc · Cited by 110
Baker, C. D., Seedorf, G., Wisniewski, B. L., Black, C. P., Ryan, S., Balasubramaniam, V., & Abman, S. H. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00400.2012 · Cited by 98
Reddy, M., Fonseca, L., Gowda, S., Chougule, B., Hari, A., & Totey, S. (2016) · International Journal of Stem Cells · doi:10.15283/ijsc16041 · Cited by 93
Karmouty‐Quintana, H., Zhong, H., Acero, L. F., Weng, T., Melicoff, E., West, J. D., Hemnes, A. R., Grenz, A., Eltzschig, H. K., Blackwell, T. S., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-200907 · Cited by 98
Inflammation‐associated remodelling and fibrosis in the lung – a process and an end point
Wallace, W. A. H., Fitch, P. M., Simpson, A. J., & Howie, S. E. M. (2007) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2006.00515.x · Cited by 90
Geiger, S., Hirsch, D. D., & Hermann, F. G. (2017) · European Respiratory Review · doi:10.1183/16000617.0044-2017 · Cited by 98
Pierce, E. M., Carpenter, K. J., Jakubzick, C., Kunkel, S. L., Flaherty, K. R., Martínez, F. J., & Hogaboam, C. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060649 · Cited by 96
Oxidative stress contributes to the induction and persistence of TGF-β1 induced pulmonary fibrosis
Cui, Y., Robertson, J. V., Maharaj, S. S., Waldhauser, L., Niu, J., Wang, J., Farkas, L., Kolb, M. R. J., & Gauldie, J. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.04.005 · Cited by 93
Self-citationNanoengineered mesenchymal stem cell therapy for pulmonary fibrosis in young and aged mice
Han, M.-M., He, X.-Y., Tang, L., Qi, L., Yang, M.-Y., Wang, Y., Xing, L., Jeong, J.-H., & Jiang, H.-L. (2023) · Science Advances · doi:10.1126/sciadv.adg5358 · Cited by 86
“However, in young mice, fibrosis was spontaneously reversed 4 weeks after intratracheal BLM instillation ( 30 ).”
Lysophosphatidic acid-1-receptor targeting agents for fibrosis
Rancoule, C., Pradère, J.-P., Gonzalez, J., Klein, J., Valet, P., Bascands, J.-L., Schanstra, J. P., & Saulnier-Blache, J.-S. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.566864 · Cited by 84
Ask, K., Martin, G. E. M., Kolb, M., & Gauldie, J. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200602-021tk · Cited by 93
Self-citationKönigshoff, M., Dumitrascu, R., Udalov, S., Amarie, O. V., Reiter, R., Grimminger, F., Seeger, W., SCHERMULY, R. T., & Eickelberg, O. (2010) · Thorax · doi:10.1136/thx.2009.134353 · Cited by 94
Mouse model of paraquat-poisoned lungs and its gene expression profile
Tomita, M., Okuyama, T., Katsuyama, H., Miura, Y., Nishimura, Y., Hidaka, K., Otsuki, T., & Ishikawa, T. (2006) · Toxicology · doi:10.1016/j.tox.2006.12.005 · Cited by 88
Martins, V., Valença, S. S., Farias-Filho, F. A., Molinaro, R., Simões, R. L., Ferreira, T. P. T., e Silva, P. M. R., Hogaboam, C. M., Kunkel, S. L., Fierro, I. M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802259 · Cited by 84
Epicatechin protective effects on bleomycin-induced pulmonary oxidative stress and fibrosis in mice
Shariati, S., Kalantar, H., Pashmforosh, M., Mansouri, E., & Khodayar, M. J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108776 · Cited by 80
The Rise and Fall of Hyaluronan in Respiratory Diseases
Lauer, M. E., Dweik, R. A., Garantziotis, S., & Aronica, M. A. (2015) · International Journal of Cell Biology · doi:10.1155/2015/712507 · Cited by 78
El‐Chemaly, S., Levine, S. J., & Moss, J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1413.017 · Cited by 80
Comparison between conventional and "clinical" assessment of experimental lung fibrosis
Ask, K., Labiris, R., Farkas, L., Moeller, A., Froese, A., Farncombe, T. H., McClelland, G. B., Inman, M. D., Gauldie, J., & Kolb, M. R. J. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-16 · Cited by 75
Self-citationInterstitial lung diseases in infants and children: Fig. 1—
Clément, A., & Eber, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00004707 · Cited by 78
Organoids as a Powerful Model for Respiratory Diseases
Li, Y., Wu, Q., Sun, X., Shen, J., & Chen, H. (2020) · Stem Cells International · doi:10.1155/2020/5847876 · Cited by 79
Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro
Ohbayashi, M., Suzuki, M., Yashiro, Y., Fukuwaka, S., Yasuda, M., Kohyama, N., Kobayashi, Y., & Yamamoto, T. (2010) · The Journal of Toxicological Sciences · doi:10.2131/jts.35.653 · Cited by 74
Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease
Lee, R., Reese, C. F., Bonner, M., Tourkina, E., Hajdu, Z., Riemer, E. C., Silver, R. M., Visconti, R. P., & Hoffman, S. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00210.2013 · Cited by 72
Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model
Wuyts, W. A., Willems, S., Vos, R., Vanaudenaerde, B. M., Vleeschauwer, S. I. D., Rinaldi, M., Vanhooren, H. M., Geudens, N., Verleden, S. E., Demedts, M., et al. (2010) · Experimental Lung Research · doi:10.3109/01902148.2010.492895 · Cited by 71
A mouse model of chronic idiopathic pulmonary fibrosis
Limjunyawong, N., Mitzner, W., & Horton, M. R. (2014) · Physiological Reports · doi:10.1002/phy2.249 · Cited by 77
Protective effect of orally administered carnosine on bleomycin-induced lung injury
Cuzzocrea, S., Genovese, T., Failla, M., Vecchio, G., Fruciano, M., Mazzon, E., Paola, R. D., Muià, C., Rosa, C. L., Crimi, N., et al. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00283.2006 · Cited by 69
Gong, G., Song, S., & Su, J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118616 · Cited by 69
Epithelial Cell Apoptosis Causes Acute Lung Injury Masquerading as Emphysema
Mouded, M., Egea, E., Brown, M. J., Hanlon, S. M., Houghton, A. M., Tsai, L. W., Ingenito, E. P., & Shapiro, S. D. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0137oc · Cited by 68
Acid Sphingomyelinase Deficiency Attenuates Bleomycin-Induced Lung Inflammation and Fibrosis in Mice
Dhami, R., He, X., & Schuchman, E. H. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000322342 · Cited by 68
Borensztajn, K., Bresser, P., van der Loos, C. M., Bot, I., van den Blink, B., den Bakker, M. A., Daalhuisen, J. B., Groot, A. P., Peppelenbosch, M. P., von der Thüsen, J. H., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091107 · Cited by 69
Static and dynamic mechanics of the murine lung after intratracheal bleomycin
Manali, E. D., Moschos, C., Triantafillidou, C., Kotanidou, A. N., Psallidas, I., Karabela, S. P., Roussos, C., Papiris, S. A., Armaganidis, A., Stathopoulos, G. T., et al. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-33 · Cited by 73
GOU, S., ZHU, T., WANG, W., XIAO, M., WANG, X.-C., & CHEN, Z.-H. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.010 · Cited by 66
Stem cell-based therapy for pulmonary fibrosis
Cheng, W., Zeng, Y., & Wang, D. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03181-8 · Cited by 65
“BLM-induced ALI and fibrosis in mice is a wellestablished model known to mimic the onset of human lung fibrosis that proceeds through the following three stages: the inflammatory stage, the fibroblast proliferation stage, and the interstitial remodeling stage [142, 143].”
BackgroundHussain, M. S., Sharma, P., Dhanjal, D. S., Khurana, N., Vyas, M., Sharma, N., Mehta, M., Tambuwala, M. M., Satija, S., Sohal, S. S., et al. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109637 · Cited by 67
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis
Froidure, A., Marchal-Duval, E., Homps-Legrand, M., Ghanem, M., Justet, A., Crestani, B., & Mailleux, A. (2020) · European Respiratory Review · doi:10.1183/16000617.0140-2019 · Cited by 55
Lymphatic Changes in Respiratory Diseases: More than Just Remodeling of the Lung?
Stump, B., Cui, Y., Kidambi, P., Lamattina, A. M., & El‐Chemaly, S. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0290tr · Cited by 61
Fitch, P. M., Howie, S. E. M., & Wallace, W. A. H. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2010.00743.x · Cited by 60
Workshop on Idiopathic Pulmonary Fibrosis in Older Adults
Castriotta, R. J., Eldadah, B. A., Foster, W. M., Halter, J. B., Hazzard, W. R., Kiley, J. P., King, T. E., Horne, F. M., Nayfield, S., Reynolds, H. Y., et al. (2010) · CHEST Journal · doi:10.1378/chest.09-3006 · Cited by 61
Tourneux, P., Markham, N. E., Seedorf, G., Balasubramaniam, V., & Abman, S. H. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00293.2009 · Cited by 62
Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol
Liu, M.-H., Lin, A., Ko, H., Perng, D., Lee, T., & Kou, Y. R. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00193 · Cited by 63
Quan, Y., Wang, Z., Gong, L., Peng, X., Richard, M. A., Zhang, J., Fornage, M., Alcorn, J. L., & Wang, D. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0586-2 · Cited by 58
Guan, C., Qiao, S., Lv, Q., Cao, N., Wang, K., Dai, Y., & Wei, Z. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.001 · Cited by 57
Hasegawa, M., Matsushita, Y., Horikawa, M., Higashi, K., Tomigahara, Y., Kaneko, H., Shirasaki, F., Fujimoto, M., Takehara, K., & Sato, S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24934 · Cited by 53
Blaauboer, M. E., Emson, C. L., Verschuren, L., van Erk, M., Turner, S., Everts, V. E., Hanemaaijer, R., & Stoop, R. (2013) · Matrix Biology · doi:10.1016/j.matbio.2013.04.005 · Cited by 56
Role of endothelial cells in pulmonary fibrosis via SREBP2 activation
Martin, M., Zhang, J., Miao, Y., He, M., Kang, J., Huang, H., Chou, C., Huang, T.-S., Hong, H.-C., Su, S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.125635 · Cited by 51
Time course of polyhexamethyleneguanidine phosphate-induced lung inflammation and fibrosis in mice
Song, J., Kim, W., Kim, Y., Kim, B., & Lee, K. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.013 · Cited by 52
Cicko, S., Grimm, M., Ayata, C. K., Beckert, J., Meyer, A., Hoßfeld, M., Zissel, G., Idzko, M., & Müller, T. (2015) · Respiratory Research · doi:10.1186/s12931-015-0264-9 · Cited by 50
A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair
Karo‐Atar, D., Bordowitz, A., Wand, O., Pasmanik‐Chor, M., Fernandez, I. E., Itan, M., Frenkel, R., Herbert, D. R., Finkelman, F. D., Eickelberg, O., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.56 · Cited by 51
Idiopathic Pulmonary Fibrosis: New Concepts in Pathogenesis and Implications for Drug Therapy
Horowitz, J. C., & Thannickal, V. J. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605050-00004 · Cited by 52
Epigenomics of Idiopathic Pulmonary Fibrosis
Yang, I. V. (2012) · Epigenomics · doi:10.2217/epi.12.10 · Cited by 54
Son, B., Kwon, T., Lee, S.-M., Han, I., Kim, W., Youn, H., & Youn, B. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2017 · Cited by 49
Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis
Nakashima, T., Yokoyama, A., Onari, Y., Shoda, H., Haruta, Y., Hattori, N., Naka, T., & Kohno, N. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.02.003 · Cited by 49
Metadata
- Authors
- Chua, F., Gauldie, J., & Laurent, G. J.
- Affiliations
- The Royal Free Hospital (GB)
- ORCID
- Chua, Felix
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 33
- Issue
- 1
- Pages
- 9-13
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2051772841
- Cited by
- 305
- References
- 36
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 10 · 2023: 24 · 2022: 18 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary fibrosis, bleomycin-induced fibrosis, experimental fibrosis, genetic modification, stem cell lines, lung repair, fibrosis pathogenesis, postgenomics
- MeSH terms
- Animals, Antimetabolites, Antineoplastic, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Lung, Lung Diseases, Models, Biological, Mutation, Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.